Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Price to Earnings (2010 - 2026)

Geron's (GERN) quarterly Price to Earnings came in at 49.33 in Q2 2026, up 10.54% year-over-year from 44.62 in Q2 2025, and up 81.54% quarter-over-quarter from 267.2 in Q1 2026.

Analysis

Geron (GERN) Price to Earnings (2010 - 2026) Analysis & Trends

Geron has disclosed Price to Earnings across 17 years of filings, most recently posting 49.33 for Q2 2026.

  • In Q2 2026, Price to Earnings rose 10.54% year-over-year to 49.33; the TTM figure through Jun 2026 stood at 12.22 (down 16.88% YoY), while the FY2025 annual figure was 10.16, up 18.29% from the prior year.
  • Price to Earnings came in at 49.33 for Q2 2026 at Geron, up from 267.2 in the prior quarter.
  • In the past five years, Price to Earnings ranged from a high of 16.72 in Q1 2022 to a low of 267.2 in Q1 2026.
  • Average Price to Earnings over 5 years is 53.34, with a median of 34.76 recorded in 2023.
  • Year-over-year, Price to Earnings soared 67.75% in 2025 and slumped 421.16% in 2026.
  • Over 5 years, Price to Earnings stood at 22.11 in 2022, then advanced by 0.01% to 22.1 in 2023, then plunged by 311.54% to 90.97 in 2024, then surged by 67.75% to 29.33 in 2025, then sank by 68.16% to 49.33 in 2026.
  • Per Business Quant data, the three most recent Price to Earnings figures were 49.33 in Q2 2026, 267.2 in Q1 2026, and 29.33 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Geron 914.60 Mn 613.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.33
Mar 31, 2026 -267.20
Dec 31, 2025 -29.33
Sep 30, 2025 -47.88
Jun 30, 2025 -55.14
Mar 31, 2025 -51.27
Dec 31, 2024 -90.97
Sep 30, 2024 -104.02
Jun 30, 2024 -37.97
Mar 31, 2024 -35.38
Dec 31, 2023 -22.10
Sep 30, 2023 -25.75
Jun 30, 2023 -34.14
Mar 31, 2023 -28.93
Dec 31, 2022 -22.11
Sep 30, 2022 -21.80
Jun 30, 2022 -20.04
Mar 31, 2022 -16.72
Dec 31, 2021 -12.34
Sep 30, 2021 -16.57